BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26439305)

  • 21.
    Martelli F; Verachi P; Zingariello M; Mazzarini M; Vannucchi AM; Lonetti A; Bacci B; Sarli G; Migliaccio AR
    Front Genet; 2021; 12():720552. PubMed ID: 34707640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. X-linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: comparisons with primary myelofibrosis.
    Åström M; Hahn-Strömberg V; Zetterberg E; Vedin I; Merup M; Palmblad J
    Am J Hematol; 2015 Mar; 90(3):E44-8. PubMed ID: 25421114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Captopril mitigates splenomegaly and myelofibrosis in the Gata1
    Corey SJ; Jha J; McCart EA; Rittase WB; George J; Mattapallil JJ; Mehta H; Ognoon M; Bylicky MA; Summers TA; Day RM
    J Cell Mol Med; 2018 Sep; 22(9):4274-4282. PubMed ID: 29971909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes.
    Manshouri T; Verstovsek S; Harris DM; Veletic I; Zhang X; Post SM; Bueso-Ramos CE; Estrov Z
    PLoS One; 2019; 14(9):e0222912. PubMed ID: 31569199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients.
    Wang X; Cho SY; Hu CS; Chen D; Roboz J; Hoffman R
    Exp Hematol; 2015 Feb; 43(2):100-9.e1. PubMed ID: 25461253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice).
    Vannucchi AM; Bianchi L; Cellai C; Paoletti F; Rana RA; Lorenzini R; Migliaccio G; Migliaccio AR
    Blood; 2002 Aug; 100(4):1123-32. PubMed ID: 12149188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pericyte coverage of abnormal blood vessels in myelofibrotic bone marrows.
    Zetterberg E; Vannucchi AM; Migliaccio AR; Vainchenker W; Tulliez M; Dickie R; Hasselbalch H; Rogers R; Palmblad J
    Haematologica; 2007 May; 92(5):597-604. PubMed ID: 17488682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow.
    Nakayama S; Yokote T; Hiraoka N; Akioka T; Nishiwaki U; Miyoshi T; Iwaki K; Fumimoto A; Masuda Y; Hatooka J; Fujimoto M; Nishimura Y; Tsuji M
    Hum Pathol; 2017 Apr; 62():180-186. PubMed ID: 28159675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathogenesis and Targeted Treatment Progress of Splenomegaly in Primary Myelofibrosis--Review].
    Chen ZW; Wang SX; Li F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):308-312. PubMed ID: 38387940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential localization of P-selectin and von Willebrand factor during megakaryocyte maturation.
    Zingariello M; Fabucci ME; Bosco D; Migliaccio AR; Martelli F; Rana RA; Zetterberg E
    Biotech Histochem; 2010 Apr; 85(3):157-70. PubMed ID: 20426698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis.
    Pizzi M; Gergis U; Chaviano F; Orazi A
    Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):96-104. PubMed ID: 27521149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.
    Ling T; Crispino JD; Zingariello M; Martelli F; Migliaccio AR
    Expert Rev Hematol; 2018 Mar; 11(3):169-184. PubMed ID: 29400094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial-to-Mesenchymal Transition in Bone Marrow and Spleen of Primary Myelofibrosis.
    Erba BG; Gruppi C; Corada M; Pisati F; Rosti V; Bartalucci N; Villeval JL; Vannucchi AM; Barosi G; Balduini A; Dejana E
    Am J Pathol; 2017 Aug; 187(8):1879-1892. PubMed ID: 28728747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis.
    Song MK; Park BB; Uhm JE
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
    J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice.
    Chagraoui H; Komura E; Tulliez M; Giraudier S; Vainchenker W; Wendling F
    Blood; 2002 Nov; 100(10):3495-503. PubMed ID: 12393681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistopathological Analysis of Extramedullary Hematopoiesis and Angiogenesis of Spleen in a Case of Primary Myelofibrosis with Huge Splenomegaly.
    Kawano N; Saito N; Yoshida S; Kitanaka A; Shide K; Marutsuka K; Ohshima K; Shimoda K
    Tohoku J Exp Med; 2022 Feb; 256(2):119-125. PubMed ID: 35173090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of myelofibrosis with myeloid metaplasia.
    Tefferi A
    J Clin Oncol; 2005 Nov; 23(33):8520-30. PubMed ID: 16293880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition.
    Wen QJ; Yang Q; Goldenson B; Malinge S; Lasho T; Schneider RK; Breyfogle LJ; Schultz R; Gilles L; Koppikar P; Abdel-Wahab O; Pardanani A; Stein B; Gurbuxani S; Mullally A; Levine RL; Tefferi A; Crispino JD
    Nat Med; 2015 Dec; 21(12):1473-80. PubMed ID: 26569382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor-beta overexpression in cutaneous extramedullary hematopoiesis of a patient with myelodysplastic syndrome associated with myelofibrosis.
    Kawakami T; Kimura S; Kato M; Mizoguchi M; Soma Y
    J Am Acad Dermatol; 2008 Apr; 58(4):703-6. PubMed ID: 18342720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.